• Je něco špatně v tomto záznamu ?

Influence of particle size and manufacturing conditions on the recrystallization of amorphous Enzalutamide

R. Svoboda, J. Romanová, S. Šlang, I. Obadalová, A. Komersová

. 2020 ; 153 (-) : 105468. [pub] 20200715

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020041

Non-isothermal differential scanning calorimetry was used to study the influences of particle size and mechanically induced defects on the recrystallization kinetics of amorphous Enzalutamide. Enzalutamide prepared by hot melt extrusion and spray-drying was used as a model material. The recrystallization rate was primarily accelerated by the presence of the processing-damaged surface of the powder particles. The actual surface/volume ratio associated with decreasing particle size fulfilled only a secondary role. Interestingly, higher quench rate during the extrusion led to a formation of thermally less stable material (with the worse stability being manifested via lower activation energy of crystal growth in the amorphous matrix). This can be the consequence of the formation of looser structure more prone to rearrangements. The recrystallization kinetics of the prepared Enzalutamide amorphous materials was described by the two-parameter autocatalytic kinetic model. The modified single-curve multivariate kinetic analysis (optimized for the data obtained at heating rate 0.5 °C•min-1) was used to calculate the extrapolated kinetic predictions of long-term isothermal crystal growth. The predictions were made for the temperatures from the range of drug shelf-life and processing for each particle size fraction. By the combination of the mass-weighted predictions for the individual powder fractions it was possible to obtain a very reasonable (temperature-extrapolated) prediction of the crystallization rate for the as-prepared unsieved powdered amorphous Enzalutamide.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020041
003      
CZ-PrNML
005      
20210830101638.0
007      
ta
008      
210728s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejps.2020.105468 $2 doi
035    __
$a (PubMed)32679178
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Svoboda, Roman $u Department of Physical Chemistry, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic. Electronic address: roman.svoboda@upce.cz
245    10
$a Influence of particle size and manufacturing conditions on the recrystallization of amorphous Enzalutamide / $c R. Svoboda, J. Romanová, S. Šlang, I. Obadalová, A. Komersová
520    9_
$a Non-isothermal differential scanning calorimetry was used to study the influences of particle size and mechanically induced defects on the recrystallization kinetics of amorphous Enzalutamide. Enzalutamide prepared by hot melt extrusion and spray-drying was used as a model material. The recrystallization rate was primarily accelerated by the presence of the processing-damaged surface of the powder particles. The actual surface/volume ratio associated with decreasing particle size fulfilled only a secondary role. Interestingly, higher quench rate during the extrusion led to a formation of thermally less stable material (with the worse stability being manifested via lower activation energy of crystal growth in the amorphous matrix). This can be the consequence of the formation of looser structure more prone to rearrangements. The recrystallization kinetics of the prepared Enzalutamide amorphous materials was described by the two-parameter autocatalytic kinetic model. The modified single-curve multivariate kinetic analysis (optimized for the data obtained at heating rate 0.5 °C•min-1) was used to calculate the extrapolated kinetic predictions of long-term isothermal crystal growth. The predictions were made for the temperatures from the range of drug shelf-life and processing for each particle size fraction. By the combination of the mass-weighted predictions for the individual powder fractions it was possible to obtain a very reasonable (temperature-extrapolated) prediction of the crystallization rate for the as-prepared unsieved powdered amorphous Enzalutamide.
650    _2
$a benzamidy $7 D001549
650    _2
$a diferenciální skenovací kalorimetrie $7 D002152
650    _2
$a krystalizace $7 D003460
650    _2
$a stabilita léku $7 D004355
650    12
$a vysoká teplota $7 D006358
650    _2
$a kinetika $7 D007700
650    _2
$a nitrily $7 D009570
650    _2
$a velikost částic $7 D010316
650    _2
$a fenylthiohydantoin $7 D010669
655    _2
$a časopisecké články $7 D016428
700    1_
$a Romanová, Jana $u Department of Physical Chemistry, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic
700    1_
$a Šlang, Stanislav $u Center of Materials and Nanotechnologies, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic
700    1_
$a Obadalová, Iva $u Zentiva, k.s., U Kabelovny 130, Prague 10, Czech Republic
700    1_
$a Komersová, Alena $u Department of Physical Chemistry, Faculty of Chemical Technology, University of Pardubice, Studentská 573, 532 10 Pardubice, Czech Republic
773    0_
$w MED00001639 $t European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences $x 1879-0720 $g Roč. 153, č. - (2020), s. 105468
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32679178 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101638 $b ABA008
999    __
$a ok $b bmc $g 1690768 $s 1140487
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 153 $c - $d 105468 $e 20200715 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...